Saturday, October 31, 2026

GBP/EUR Bullish Momentum: 0.81% Up In The Last 5 Sessions

ViaNews Editorial Team

November 27, 2023

GBP/EUR Bullish Momentum: 0.81% Up In The Last 5 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 0.81% for the last 5 sessions. At 23:09 EST on Sunday, 26 November, GBP/EUR (GBPEUR) is $1.15.

GBP/EUR's yearly highs and lows, it's 3.367% up from its 52-week low and 2.209% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.06%, a negative 0.01%, and a positive 0.19%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.25% (last week), 0.20% (last month), and 0.19% (last quarter), respectively.

News about

  • Eur/usd: growth outlook in the eurozone does not point to much upside scope – MUFG. According to FXStreet on Friday, 24 November, "We have been keen to stress that while the window for Dollar appreciation back to the highs set in October and/or beyond may now have closed, the growth outlook in the Eurozone does not point to much upside scope for EUR/USD either."
  • Eur/usd: weekly forecast 26th November - 2nd December - 26 November 2023. According to DailyForex on Sunday, 26 November, "However, importantly the high made in the EUR/USD on Tuesday of last week is noteworthy because it hit values last seen in the second week of August. ", "This is only an interpretation of the EUR/USD marketplace through my perspective, but the fact the currency pair incrementally climbed after the lows on Wednesday could show that buying sentiment remains intact."
  • Eur/usd catches a Friday bid, looking to climb over 1.0950. According to FXStreet on Friday, 24 November, "The EUR/USD is trading into the 1.0950 level as the trading week winds up and markets are set for an early volume drop-off with US money markets shuttering early for the weekend. ", "The Euro is grinding higher against the US Dollar heading into Friday's market close, with the EUR/USD pushing towards 1.0950, but the pair still remains below the week's peak at 1.0965."
  • Eur/usd gains ground above 1.0900 on the stronger eurozone pmi, US PMI data looms. According to FXStreet on Friday, 24 November, "The EUR/USD pair trades in positive territory above 1.0900 during the early Asian trading hours on Friday. ", "Traders will take cues from these figures and find trading opportunities around the EUR/USD pair."
  • According to FXStreet on Friday, 24 November, "The Euro maintainsits bullishmomentum against the US Dollar, prompting EUR/USD to build on Thursday's gains just beyond 1.0900at the end of the week.", "Further north, EUR/USD may encounter resistance at the August top of 1.1064 (August 10) and another weekly peak of 1.1149 (July 27), both preceding the 2023 high of 1.1275 (July 18)."

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com